This information sheet discusses the need for individuals with latent TB infection (LTBI) to get treatment and prevent the progression of LTBI to TB disease. It emphasizes the importance of the health care provider communicating the value of LTBI treatment and of identifying barriers to adherence...
This information sheet discusses preventing occupational transmission of TB by means of an infection control program. It explains the three levels of TB infection control in health care settings: (1) administrative controls to minimize areas where exposure may occur; (2) environmental controls to...
This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at...
These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals.
This information sheet discusses TB and the risk for international travelers. It explains TB transmission, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of the disease, and how drug resistance occurs. The information sheet considers whether international travelers are at...
Using a question-and-answer format, this pamphlet provides general information about TB, including transmission, symptoms, and the difference between TB infection and disease. The pamphlet explains both a blood and skin test, the procedures that are followed if the test result is negative or...
This document is intended for use as a reference manual for clinicians caring for persons with or at high risk for TB disease or infection. It is not meant to provide detailed answers to all public health or clinical questions about TB, and it is not meant as a substitute for any specific...
This handbook is a reference tool for use by national tuberculosis (TB) program managers, clinicians and nurses, public health decision-makers and technical and implementing partners committed to the prevention, care, diagnosis and treatment of drug-resistant TB.
This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB, which is used in many countries to prevent childhood tuberculous meningitis and miliary TB. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered...